Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 59, 2776-2780, June 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffin, C. A.
Right arrow Articles by Perlman, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffin, C. A.
Right arrow Articles by Perlman, E. J.
[Cancer Research 59, 2776-2780, June 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Recurrent Involvement of 2p23 in Inflammatory Myofibroblastic Tumors

Constance A. Griffin1, Anita L. Hawkins, Cecily Dvorak, Carol Henkle, Tara Ellingham and Elizabeth J. Perlman

Departments of Pathology [C. A. G., A. L. H., C. D., C. H., T. E., E. J. P.] and Oncology [C. A. G., E. J. P.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287

Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor. The reactive versus neoplastic pathogenesis of this tumor is unresolved. We found clonal chromosome aberrations involving 2p23 upon metaphase analysis of two IMTs. Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochemistry revealed ALK expression in all three cases. 2p22–24 involvement has been reported previously in four additional cases of IMT. We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
B C Gleason and J L Hornick
Inflammatory myofibroblastic tumours: where are we now?
J. Clin. Pathol., April 1, 2008; 61(4): 428 - 437.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. M. Amin and R. Lai
Pathobiology of ALK+ anaplastic large-cell lymphoma
Blood, October 1, 2007; 110(7): 2259 - 2267.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. S. J. Elenitoba-Johnson, D. K. Crockett, J. A. Schumacher, S. D. Jenson, C. M. Coffin, A. L. Rockwood, and M. S. Lim
Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins
PNAS, May 9, 2006; 103(19): 7402 - 7407.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A J Clarke, T S Jacques, M J Galloway, M Thom, N D Kitchen, and G T Plant
ALK positive inflammatory myofibroblastic tumour of the pineal region
J. Clin. Pathol., September 1, 2005; 58(9): 981 - 983.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Melloni, A. Carretta, P. Ciriaco, G. Arrigoni, S. Fieschi, N. Rizzo, E. Bonacina, G. Augello, P. A. Belloni, and P. Zannini
Inflammatory Pseudotumor of the Lung in Adults
Ann. Thorac. Surg., February 1, 2005; 79(2): 426 - 432.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S.-H. Chon, C. B. Lee, and Y.-H. Oh
Calcifying fibrous pseudotumor causing thoracic outlet syndrome
Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 353 - 355.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
W. Cheuk and J. K. C. Chan
Subcellular Localization of Immunohistochemical Signals: Knowledge of the Ultrastructural or Biologic Features of the Antigens Helps Predict the Signal Localization and Proper Interpretation of Immunostains
International Journal of Surgical Pathology, July 1, 2004; 12(3): 185 - 206.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
M. Debiec-Rychter, R. Croes, R. De Vos, P. Marynen, T. Roskams, A. Hagemeijer, R. Lombaerts, and R. Sciot
Complex Genomic Rearrangement of ALK Loci Associated with Integrated Human Epstein-Barr Virus in a Post-Transplant Myogenic Liver Tumor
Am. J. Pathol., September 1, 2003; 163(3): 913 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
N. S. Reading, S. D. Jenson, J. K. Smith, M. S. Lim, and K. S. J. Elenitoba-Johnson
5'-(RACE) Identification of Rare ALK Fusion Partner in Anaplastic Large Cell Lymphoma
J. Mol. Diagn., May 1, 2003; 5(2): 136 - 140.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
L. D. Narla, B. Newman, S. S. Spottswood, S. Narla, and R. Kolli
Inflammatory Pseudotumor
RadioGraphics, May 1, 2003; 23(3): 719 - 729.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. L. Kutok and J. C. Aster
Molecular Biology of Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma
J. Clin. Oncol., September 1, 2002; 20(17): 3691 - 3702.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
A. F. Nascimento, R. Ruiz, J. L. Hornick, and C. D. M. Fletcher
Calcifying Fibrous 'Pseudotumor': Clinicopathologic Study of 15 Cases and Analysis of its Relationship to Inflammatory Myofibroblastic Tumor
International Journal of Surgical Pathology, July 1, 2002; 10(3): 189 - 196.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
J. A. Bridge, M. Kanamori, Z. Ma, D. Pickering, D. A. Hill, W. Lydiatt, M. Y. Lui, G. W. B. Colleoni, C. R. Antonescu, M. Ladanyi, et al.
Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor
Am. J. Pathol., August 1, 2001; 159(2): 411 - 415.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
R. Suzuki, M. Seto, S. Nakamura, A. Nakagawa, K. Hara, and K. Takeuchi
Sarcomatoid Variant of Anaplastic Large Cell Lymphoma with Cytoplasmic ALK and {{alpha}}-Smooth Muscle Actin Expression: A Mimic of Inflammatory Myofibroblastic Tumor
Am. J. Pathol., July 1, 2001; 159(1): 383 - 384.
[Full Text] [PDF]


Home page
BloodHome page
H. Stein, H.-D. Foss, H. Durkop, T. Marafioti, G. Delsol, K. Pulford, S. Pileri, and B. Falini
CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Blood, December 1, 2000; 96(12): 3681 - 3695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Lawrence, A. Perez-Atayde, M. K. Hibbard, B. P. Rubin, P. Dal Cin, J. L. Pinkus, G. S. Pinkus, S. Xiao, E. S. Yi, C. D. M. Fletcher, et al.
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Am. J. Pathol., August 1, 2000; 157(2): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. W. B. Colleoni, J. A. Bridge, B. Garicochea, J. Liu, D. A. Filippa, and M. Ladanyi
ATIC-ALK: A Novel Variant ALK Gene Fusion in Anaplastic Large Cell Lymphoma Resulting from the Recurrent Cryptic Chromosomal Inversion, inv(2)(p23q35)
Am. J. Pathol., March 1, 2000; 156(3): 781 - 789.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.